ArticleNPJ precision oncology2026

IL-1-mediated inflammation promotes metastatic dissemination and resistance to EGFR-targeted therapy.

Federica Pagano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.